Archive for the ‘EP and UK Practice’ Category

From The EPO: Oral Proceedings/Interviews Before Examining Division Can Be Held Via Videoconferencing

Thursday, June 14th, 2012

This is a guest post from Lynnea Fedyk, legal process assistant at Schwegman, Lundberg & Woessner, P.A.

Attached are two documents of particular interest regarding Oral Proceedings by video conference and submission of email during video conference.

Should you like to view the complete listing of contents in the Official Journal – May 2012, please go to

Should you like to view the complete EPO newsletter, please go to

 Oral Proceedings by Video Conference

Interviews and Oral Proceedings – Submission of email

Patentability Of Surgical Methods – New Insights From The EPO

Friday, May 18th, 2012

This is a guest post from Dr. Stefan Danner
Patentanwalt/German Patent Attorney, European Patent Attorney

In its previous decision G1/07, the EPO Enlarged Board of Appeal (EBA) shed new light on the patentability of surgical methods, particularly those forming part of diagnostic methods. Based on this ruling the range of patentable subject matter is now limited in that methods that are surgical by nature but not necessarily by purpose are not deemed eligible for patent protection according to Article 53(c) EPC[1]


“Handbook of Quality Procedures Before the EPO”

Monday, March 26th, 2012

The ECP, epi and Business Europe have collaborated to produce a downloadable, fifty page guide to practice before the EPO. While not binding on Examiners, it was issued under the authority of the EPO and is a sort of mini-MPEP, intended for use by both applicants and Examiners. A copy is provided at the end of this post. You can read more about it here.


Recent Rulings of the European Court of Justice on SPCs

Wednesday, January 4th, 2012

Attached you will find the newsletter from DHS Patentanwalts GmbH, provided to us by Dr. Stefan Danner.

In the last few months, the European Court of Justice (ECJ) has handed down several decisions relating to the grant and validity of supplementary protection certificates (SPCs; i.e. patent term extensions). Thereof, the following rulings are generally considered to have significant impact on IP strategies in the pharmaceutical industry.

12 11 EJC rulings on SPCs